L-Carnitine - Metabolic functions and meaning in humans life

Current Drug Metabolism

Volumn 12, Issue 7, 2011, Pages 667-678

  Pȩkala, Jolanta ^a   Patkowska Sokoła, Bozena ^b   Bodkowski, Robert ^b   Jamroz, Dorota ^b   Nowakowski, Piotr ^b   Lochyński, Stanisław ^a,c   Librowski, Tadeusz ^d  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^b WROC AW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

^c Institute of Cosmetology   (Poland)

^d JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Cardiovascular disorders; Carnitine deficiency; CATs; Fat metabolism; Functional food.; L carnitine; OCTNs

Indexed keywords

AMINO ACID; CARNITINE; LYSINE; METHIONINE;

ANGINA PECTORIS; DIET SUPPLEMENTATION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; HEART FAILURE; OXIDATIVE STRESS; REVIEW; WEIGHT REDUCTION;

ANIMALS; CARNITINE; DIETARY SUPPLEMENTS; HEART FAILURE; HUMANS; LIPID METABOLISM; METABOLIC NETWORKS AND PATHWAYS; OXIDATIVE STRESS;

EID: 79961064450     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/138920011796504536     Document Type: Review

References (123)

1. Alesci, S.; De Martino, M. U.; Mirani, M.; Benvenga, S.; Trimarchi, F.; Kino, T.; Chrousos, G.P. L-Carnitine: a nutritional modulator of glucocorticoid receptor functions. The FASEB Journal, EPub, 2003, 17, 1553-1555.
2. Karlic, H.; Lohninger, A. Supplementation of L-carnitine in athletes: does it make sense? Nutrition, 2004, 20(7-8), 709-715. (Pubitemid 38798089)
3. Peluso, G.; Barbarisi, A.; Savica V.; Reda, E.; Nicolai, R.; Benatti, P.; Calvani, M. Carnitine: An osmolyte that plays a metabolic role. J. Cell. Biochem, 2001, 80(1), 1-10.
4. Fraenkel, G.; Friedman, S. Carnitine. Vitam. Horm., 1957, 15, 73-118.
5. Seim, H.; Eichler, K.; Kleber, H. L(-)-Carnitine and its precursor, gamma-butyrobetaine. In: Kramer, K.; Hoppe, P.; Packer, L.; eds. Nutraceuticals in Health and Disease Prevention, New York, Marcel Dekker, Inc., 2001; pp. 217-256.
6. Vogt, C.; Georgi, A.; Werner, G. Enantiomeric Separation of D/Lcarnitine using HPLC and CZE after Derivatization. Chromatographia, 1995, 40(5-6), 287-295.
7. Hanschmann, H.; Kleber, H.-P. Conversion of D-carnitine into Lcarnitine with stereospecific carnitine dehydrogenases. Biotechnol. Lett., 1997, 19(7), 679-682. (Pubitemid 27321092)
8. Evans, A.; Faull, R.; Fornasini, G.; Lemanowicz, E.; Longo, A.; Pace, S.; Nation, R. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis. Clin. Pharmacol. Ther., 2000, 68(3), 238-249.
9. Demarquoy, J.; Georges, B.; Rgault, C.; Royer, M.C.; Clairet, A.; Soty, M.; Lekounoungou, S.; Le Borgne F. Radioisotopic determiantion of L-carnitine content in foods commonly eaten in Western countries. Food Chem., 2004, 86, 137-142. (Pubitemid 38199899)
10. Di Donato, S.; Cornelio, F.; Balestrini, M. R.; Bertagnolio, B.; Pluchetti, D. Mitochondria-lipid glycogen myopathie, hyperlactacidemia, and L-carnitine deficiency. Neurology, 1978, 28(11), 1110-1116. (Pubitemid 9012851)
11. Chalmers, R. A.; Roe, C. R.; Stacey, T. E.; Hoppel, C. L. Urinary excretion of L-carnitine and acyl-L-carnitine by patients with disorders of organic acid metabolism: evidence for secondary insufficient of L-carnitine. Pediatr. Res., 1984, 18, 1325-1328. (Pubitemid 15221487)
12. Vaz, F. M.; Wanders, R. J. Carnitine biosynthesisi in mammals. Biochem. J., 2002, 361, 417-429.
13. Rebouche, C. J.; Lehman, L. J.; Olson, L. J. Epsilon-Ntrimethyllysine availability regulates the rate of carnitine biosynthesis in the growing rat. J. Nutr., 1986, 116, 751-759. (Pubitemid 16111254)
14. Van Vlies, N.; Wanders, R.J.A.; Vaz, F.M. Measurement of carnitine biosynthesis enzyme activities by tandem mass spectrometry: Differences between the mouse and the rat. Anal. Biochem., 2006, 354, 132-139. (Pubitemid 43816394)
15. Paik, W. K.; Nochumson, S.; Kim, S. Carnitine biosynthesis via protein methylation. Trends Biochem. Sci., 1977, 2, 159-161.
16. Galland, S.; Le Borgne, F.; Bouchard, F.; Georges, B.; Clouet, P.; Grand-Jean, F.; Demarquoy, J. Molecular cloning and characterization of the cDNA encoding the rat liver c-butyrobetaine hydroxylase. Biochim. Biophys. Acta, 1999, 1441(1), 85-92. (Pubitemid 29469440)
17. Hahn, P. The development of carnitine synthesis from cbutyrobetaine in the rat. Life Sci., 1981, 28, 1057-1060. (Pubitemid 11110092)
18. Berardi, S.; Stieger, B.; Wachter, S.; O'Neill, B.; Krahenbuhl, S. Characterization of a sodium-dependent transport system for butyrobetaine into rat liver plasma membrane vesicles. Hepatology, 1998, 28, 521-525. (Pubitemid 28363681)
19. Englard, S. Hydroxylation of gamma-butyrobetaine to carnitine in human and monkey tissues. FEBS Lett., 1979, 102, 297-300. (Pubitemid 9221721)
20. Bremer, J. Carnitine-metabolism and functions. Physiol. Rev., 1983, 63, 1420-1480.
21. Stanley, C. A. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency. Adv. Pediatr., 1987, 34, 59-88.
22. Berardi, S.; Stieger, B.; Hagenbuch, B.; Carafoli, E.; Krahenbuhl, S. Characterization of L-carnitine transport into rat skeletal muscle plasma membrane vesicles. Eur. J. Biochem., 2000, 267, 1985-1994. (Pubitemid 30185284)
23. Bahl, J.; Navin, T.; Manian, A. A.; Bressler, R. Carnitine transport in isolated adult rat heart myocytes and the effect of 7,8-diOH chlorpromazine. Circ. Res., 1981, 48, 378-385. (Pubitemid 11102701)
24. Nalecz, K. A.; Miecz, D.; Berezowski, V. Carnitine: transport and physiological functions in the brain. Mol. Aspects Med., 2004, 25, 551-567. (Pubitemid 39195076)
25. Reuter, S.E.; Evans, A.M.; Chace, D.H.; Fornasini, G. Determination of the reference range of endogenous plasma carnitines in healthy adults. Ann. Clin. Biochem., 2008, 45, 585-592.
26. Lahjouji, K.; Mitchell, G. A.; Quereshi, I. A. Carnitine transport by organic cation transporters and systemic carnitine deficiency. Mol. Genet. Metab., 2001, 73, 287-297. (Pubitemid 32846367)
27. Grube, M.; Meyer zu Schwabedissen, H. E.; Prager, D. Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5). Circulation, 2006, 113, 1114-1122.
28. Nezu, J.; Tamai, I.; Oku, A.; Ohashi, R.; Yabuuchi, H.; Hashimoto, N.; Nikaido, H.; Sai, Y.; Koizumi, A.; Shoji, Y.; Takada, G.; Matsuishi, T.; Yoshino, M.; Kato, H.; Ohura, T.; Tsujimoto, G.; Hayakawa, J.; Shimane, M.; Tsuji, A. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium iondependent carnitine transporter. Nat. Genet., 1999, 21, 91-94. (Pubitemid 29036290)
29. Karlic, H.; Lohninger, A.; Laschan, C.; Lapin, A.; Bohmer, F.; Huemer, M.; Guthann, E.; Rappold, E.; Pfeilstocker, M. Downregulation of carnitine acyltransferases and organic cation transporter OCTN2 in mononuclear cells in healthy elderly and patients with myelodysplastic syndromes. J. Mol. Med., 2003, 81, 435-442. (Pubitemid 36900539)
30. Brown, H.-R.; Ni, H.; Benavides, G.; Yoon, L.; Hyder, K.; Giridhar, J.; Gardner, G.; Tyler, R.-D.; Morgan, K.-T. Correlation of simultaneous differential gene expression in the blood and heart with known mechanisms of adriamycin-induced cardiomyopathy in the rat. Toxicol. Pathol., 2002, 30, 452-469.
31. Yabuuchi, H.; Tamai, I.; Oczu, J.I.; Sakamoto, K.; Oku, A.; Shimane, M.; Sai, Y.; Tsuji, A. J. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J. Pharmacol. Ex. Ther., 1999, 289, 768-773. (Pubitemid 29191230)
32. Horiuchi, M.; Kobayashi, K.; Yamaguchi, S.; Shimizu, N.; Koizumi, T.; Nikaido, H.; Hayakawa, J.; Kuwajima, M.; Saheki, T. Primary defect of juvenile visceral steatosis (jvs) mouse with systemic carnitine deficiency is probably in renal carnitine transport system. Biochim. Biophys. Acta, 1994, 1226, 25-30. (Pubitemid 24123051)
33. Koepsell, H.; Lips, K.; Volk, C. Polyspecific organic cation transporters: structure, function, physiological
34. d biopharmaceutical implications. Pharm. Res., 2007, 24, 1227-1251.
35. Lamhonwah, A. M.; Wong, J.; Tam, C.; Mai, L.; Tein, I. Organic cation/carnitine transporter family expression patterns in adult murine heart. Pathol. Res. Pract., 2009, 205, 395-401.
36. Evans, A.M.; Fornasini, G. Pharmacokinetics of L-carnitine. Clin. Pharmacokinet., 2003, 42, 941-967. (Pubitemid 37056103)
37. Ramsay, R.R.; Gandour, R.D.; van der Leij, F.R. Molecular enzymology of carnitine transfer and transport. Biochim. Biophys. Acta, 2001, 1546, 21-43. (Pubitemid 32217800)
38. Rebouche, C.J.; Lombard, K. A.; Chenard, C. A. Renal adaptation to dietary carnitine in humans. Am. J. Clin. Nutr., 1993, 58, 660-665. (Pubitemid 23319953)
39. Lombard, K. A.; Olson, A. L. Carnitine status of lactoovovegetarians and strict vegetarian adults and children. Am. J. Clin. Nutr., 1989, 50, 301-306. (Pubitemid 19208747)
40. Czeczot, H.; Ścibol, D. Role of L-carnitine in metabolizm, nutrition and therapy. Postepy Hig. Med. Dosw. Epub, 2005, 59, 9-19
41. Knuttel-Gustavsen, S.; Harmeyer, J. The determination of Lcarnitine in several ford samples. Food Chem., 2007, 105, 793-804.
42. Krajcovicova-Kudlackova, M.; Simoncic, R.; Bederova, A.; Babinska, K.; Beder, I. Correlation of carnitine levels to methionine and lysine intake. Physiol. Res., 2002, 49, 399-402. (Pubitemid 30646838)
43. Bach, A.C. Carnitine in human nutrition. Z. Ernahrungswiss., 1982, 21, 257-265. (Pubitemid 13149252)
44. Pietrzak, I.; Opala, G. Rola karnityny w przemianie lipidowej człowieka. Wiad. Lek., 1998, 51, 71-75.
45. Rebouche, C.J.; Chenard, C.A. Metabolic fate of dietary carnitine in human adults: identification and quantification of urinary and fecal metabolites. J. Nutr., 1991, 121, 539-546.
46. Rebouche, C.J.; Carnitine. In: Shils, M.E.; Shike, M.; Ross, A.C.; Caballero, B.; Cousins, R.J.; eds. Modern Nutrition in Health and Disease. 10th ed. Philadelphia: Lippincott, Williams & Wilkins; 2006; pp. 537-544.
47. Rebouche, C.J. Kinetics, pharmacokinetics, and regulation of Lcarnitine and acetyl-L-carnitine metabolism. Ann. N. Y. Acad. Sci., 2004, 1033, 30-41. (Pubitemid 39656736)
48. Gudjonsson, H.; Li, B.U.K.; Shug, A.L.; Olsen W.A. Studies of carnitine metabolism in relation to intestinal absorption. Am. J. Physiol., 1985, 248, 313-319.
49. Li, B.U.K.; Bummer, P. M.; Hamilton, J.W.; Gudjonsson, H.; Zografi, G.; Olsen, W.A. Uptake of L-carnitine by rat jejunal brush border microvillous membrane vesicles. Digest. Dis. Sci., 1990, 35, 333-339. (Pubitemid 20069529)
50. Rebouche, J.C.; Engels, A.G. Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes. J. Clion. Invest., 1984, 73, 957-867.
51. Marzo, A.; Arrigoni-Martelli, E.; Urso, R.; Rocchetti, M.; Rizza, V.; Kelly, J.G. Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers. Eur. J. Clin. Pharmacol., 1989, 37,59-63. (Pubitemid 19197495)
52. Slitt, A.L.; Cherrington, N.J.; Hartley, D.P.; Leazer, T.M.; Klaassen, C.D. Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels. Drug Metab. Dispos., 2002, 30, 212-219. (Pubitemid 34106542)
53. Rebouche, C.J.; Lombard, K.A.; Chenard, C.A. Renal adaptation to dietary carnitine in humans. Am. J. Clin. Nutr., 1993, 58, 660-665. (Pubitemid 23319953)
54. Cederblad, G. Effect of diet on plasma carnitine levels and urinary carnitine exrection in humans. Am. J. Clin. Nutr., 1987, 45, 725-729. (Pubitemid 17077916)
55. Cederblad, G.; Fahraeus, L.; Lindgren, K. Plasma carnitine and renal carnitine clearance during pregnancy. Am. J. Clin. Nutr., 1986, 44, 379-383. (Pubitemid 16052628)
56. Cederblad, G.; Engstroem, G. Effect of thyroxine treatment on carnitine levels in mice. Acta Pharmacol. Toxicol., 1978, 43, 1-5. (Pubitemid 8404433)
57. Melegh, B.; Kerner, J.; Bieber, L.L. Pivampicillin-promoted excretion of pivaloylcarnitine in humans. Biochem. Pharmacol., 1987, 36, 3405-3409. (Pubitemid 18012212)
58. Wagner, C.A.; Lukewille, Y.U.; Kaltenbach, S.; Moschen, I.; Broer, A.; Risler, T.; Broer, S.; Lang, F.; Functional and pharmacological characterization of human Na+-carnitine cotransporter hOCTN2. Am. J. Physiol. Renal. Physiol., 2000, 279, 584-591.
59. Koepsell, H. Polyspecific organic cation transporters: their functions and interactions with drugs. Trends Pharmacol. Sci., 2004, 25, 375-381. (Pubitemid 38829491)
60. Bain1, M.A.; Faull, R.; Milnel, R.W.; Evansl, A.M. Oral Lcarnitine: metabolite formation and hemodialysis. Curr. Drug Metab., 2006, 7, 811-816. (Pubitemid 44509682)
61. Strack, E.; Seim, H. Die Bildung von γ-Butyrobetain aus exogenem L(-)-Carnitin in vivo bei Maus und Ratte. Hoppe Seylers Z. Physiol. Chem., 1979, 360, 207-215. (Pubitemid 9154992)
62. Rebouche, C.J.; Mack, D.L.; Edmonson, P.F. L-Carnitine dissimilation in the gastrointestinal tract of the rat. Biochem., 1984, 23, 6422-6426. (Pubitemid 15167729)
63. Rebouche, C.J.; Seim, H. Carnitine metabolizm and its regulation in microorganism and mammals. Ann. Rev. Nutr., 1998, 18, 39-61. (Pubitemid 28366860)
64. Unemoto, T.; Hayashi, M.; Miyaki, K.; Hayashi, M. Formation of trimethylamine from DL-carnitine by Serratia marcescens. Biochim. Biophys. Acta, 1966, 121, 220-222.
65. Miura-Fraboni, J.; Kleber, H.-P.; Englard, S. Assimilation of 7- butyrobetaine, and D- and L-carnitine by resting cell suspensions of Acinetobacter calcoaceticus and Pseudomonas putida. Arch. Microbiol., 1982, 133, 217-221. (Pubitemid 13185775)
66. Seim, H.; Ezold, R.; Kleber, H.-P.; Strack, E. Stoffwechsel des Lcarnitins bei Enterobakterien. Z. Allg. Mikrobiol., 1980, 20, 591-594.
67. Demarquoy, J. Radioscopic determination of L-carnitine content in foods commonly eaten in Western countries. Food Chem., 2004, 86, 137-142. (Pubitemid 38199899)
68. Colucci, W.J.; Gandour, R.D. Carnitine acetyltransferase - a review of its biology, enzymology, and bioorganic chemistry. Bioorg. Chem., 1988, 16, 307-334.
69. Van der Leij, F.R. Genomics of the human carnitine acyltransferase genes. Mol. Genet. Metab., 2000, 71, 139-153.
70. Ramsay, R.R. The carnitine acyltransferases: modulator sof azyl- CoA-dependent reactions. Biochem. Soc. Trans., 2000, 28, 182-186.
71. Corti, O.; Finocchiaro, G.; Rossi, E.; Zuffardi, O.; DiDonato, S. Molecular cloning of cDNAs encoding human carnitine acyltransferase and mapping of the corresponding gene to chromosome 9q34.1. Genomics, 1994, 23, 94-99. (Pubitemid 24296939)
72. Chase, J. F.; Tubus, P. K. Some kinetics studies on the mechanism of action of carnitine acetyltransferase. Biochem. J., 1966, 99, 32-40.
73. Chase, J.F.; Tubus, P. K. Conditions for the self-catalysed inactivation of carnitine acetyltransferase. Biochem. J., 1969, 111, 225-235.
74. Wu, D.; Govindasamy, L.; Lian, W.; Gu, Y.; Kukar, T. Structure of human carnitine acetyltransferase. J. Biol. Chem., 2003, 278, 13159-13165.
75. Ramsay, R.R.; Naismith, J.H. A snapshot of carnitine acetyltransferase. Trends Biochem. Sci., 2003, 28, 343-346. (Pubitemid 36851611)
76. Abumrad, N.N.; Williams, P.; Frexes-Steed, M.; Geer, R.; Flakoll, P.; Cersosimo, E.; Brown, L.L.; Melki, I.; Bulus, N.; Hourani, H.; Hubbard, M.; Ghshan, F. Inter-organ metabolism of amino acids in vivo. Diabetes Metab. Rev., 1989, 5, 213-226. (Pubitemid 19116191)
77. Jeukendrup, A.E. Regulation of fat metabolism in skeletal muscle. Ann. N.Y. Acad. Sci., 2002, 967, 217-235. (Pubitemid 34721908)
78. Kuwajima, M.; Kono, N.; Horiuchi, M.; Imamura, Y.; Ono, A.; Inui, Y.; Kawata, S.; Koizumi, T.; Hayakawa, J.; Saheki, T.; Tarui, S. Animal model of systemic carnitine deficiency: Analysis in C3H-H-2° strain of mouse ssociated with juvenile visceral steatosis. Biochem. Biophys. Res. Co., 1991, 174, 1090-1094.
79. Lu, K.; Nishimori, H.; Nakamura, Y.; Shima, K.; Kuwajima, M. A missense mutation of mouse OCTN2, a sodium-dependent carnitine cotransporter, in the juvenile visceral steatosis morse. Biochem. Biophys. Res. Co., 1998, 252, 590-594 (Pubitemid 28556821)
80. Cotton, L.; Rodriguez, C.; Suzuki, K.; Orgebin-Crist, M.; Hinton, B. Organic cation/carnitine transporter, OCTN2, transcriptional activity is regulated by osmotic stress in epididymal Wells. Mol. Reprod. Dev., 2010, 77, 114-125.
81. Montfoort1, J.E.; Hagenbuch, B.; Groothuis, G.M.M.; Koepsell, H.; Meier, P.J.; Meijer, D.K.F. Drug uptake systems in liver and kidney. Curr. Drug Metab., 2003, 4, 185-211. (Pubitemid 36656478)
82. Shoji, Y.; Koizumi, A.; Kayo, T.; Ohata, T.; Takahashi, T.; Harada, K.; Takada, G. Evidence for linkage of human primary systemic carnitine deficiency with D5S436: A novel gene locus on chromosome 5q. Am. J. Hum. Genet., 1998, 63, 101-108. (Pubitemid 30428324)
83. Rinaldo, P.; Stanley, C.A.; Hsu, B.Y.L.; Sabchez, L.A.; Stern, H.J. Sudden neonatal death in carnitine transporter deficiency. J. Pediatr., 1997, 131, 304-305. (Pubitemid 27495255)
84. Bonner, C.M.; DeBrie, K.; Hug, G.; Landrigan, E.; Taylor, B.J. Effects of parenteral L-carnitine supplementation on fat metabolism and nutrition in premature neonates. J. Pediatr., 1995, 126, 287-292.
85. Siliprandi, N.; Sartorelli, L.; Liman, M.; Di Lisa, F. Carnitine: metabolism and clinical chemistry. Clin. Chim. Acta, 1989, 183, 3-12. (Pubitemid 19179558)
86. Soltesz, G.; Melegh, B.; Sandor, A. The relationship between carnitine and ketone body levels in diabetic children. Acta Pediatr. Scand., 1983, 72, 511-515. (Pubitemid 13062861)
87. Spagnoli, L.G.; Corsi, M.; Villaschi, S.; Palamieri, G.; Maccari, F. Myocardial carnitine deficiency in acute myocardial infarction. Lancet, 1982, 1, 1419-1420.
88. Debska-Slizien, A.; Owczarzak, A.; Krol, E. The influence of Lcarnitine and simultaneous erythropoetin and L-carnitine administration on erythrocyte metabolism in hemodialysis patients. Adv. Renal Nutr. Metab. Ed. Bios., 1997, 137-144.
89. Fagher, B.; Cederblad, G.; Monti, M.; Olsson, L.; Rasmussen, B.; Thysell, H. Carnitine and left ventricular function in haemodialysis patients. Scand. J. Clin. Lab. Invest., 1985, 45, 193-198. (Pubitemid 15050972)
90. Demeyere, R.; Lormans, P.; Weidler, B.; Minten, J.; Van Aken, H.; Flameng, W. Cardioprotective effects of carnitine in extensive aortocoronary bypass grafting: A double-blind, randomized, placebocontrolled clinical trial. Anesth. Analg., 1990, 71, 520-528. (Pubitemid 20380602)
91. Iliceto, S.; Scrutinio, D.; Bruzzi, P.; D'Ambrosio, G.; Boni, L.; Biasco, G. Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: The Lcarnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial. J. Am. Coll. Cardiol., 1995, 26, 380-387.
92. Arsenian, M.A.; New, P.S.; Cafasso, C.M. Safety, tolerability, and efficacy of a glucose-insulin-potassium-magnesium-carnitine solution in acute myocardial infarction. Am. J. Cardiol., 1996, 78, 476-479. (Pubitemid 26277031)
93. Chiddo, A.; Gaglione, A.; Musci, S. Hemodynamic study of intravenous propionyl-L-carnitine in patients with ischeic heart disease and normal left ventricular function. Cardiovasc. Drugs Ther., 1991, 5, 107-111.
94. Ferrari, R.; Cuchini, F.; DiLisa, F. The effect of L-carnitine on myocardial metabolism of patients with coronary artery disease. Clin. Trials. J., 1984, 21, 40-50.
95. Stanley, W.C. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc. Res., 1997, 33, 243-257. (Pubitemid 27072627)
96. Arsenian, M.A. Carnitine and its derivatives in cardiovascular disease. Progr. Cardiovasc Dis., 1997, 40, 265-286. (Pubitemid 28008762)
97. Harman, D. Ageing process. Proc. Natl. Acad. Sci. USA, 1981, 78, 7124-7128.
98. Reiter, R. J. Oxidative damage in the central nervous system: protection by melatonin. Progr. Neurobiol., 1998, 56, 359-384. (Pubitemid 28389724)
99. Hagen, T.M.; Vinarsky, V.; Wehr, C.M.; Ames, B.N. (R)-α-Lipoic acid reverses the age-associated increase in susceptibility of hepatocytes to tert-butylhydroperoxide both in vitro and in vivo. Antioxid. Redox Sign., 2000, 2, 473-483.
100. Liu, J.; Head, E.; Gharib, A.M.; Yuan, W.; Ingersoll, R.T.; Hagen, T.M.; Cotman, C.W.; Ames, B.N. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: Partial reversal by feeding acetyl-L-carnitine and/or R-α-lipoic acid. Proc. Natl. Acad. Sci., 2002, 99, 2356-2361. (Pubitemid 34169065)
101. Jayakumar, P.; Di Silvio, L. Osteoblasts in bone tissue engineering. Proc. I. Mech. E. Part H: J. Engineering in Medicine, 2010, 224, 1415-1440.
102. Cavazza, C. Composition for the prevention and treatment of osteoporosis due to menopause syndrome. US Patent, 6,335,038, 2002.
103. Hooshmand, S.; Balakrishnan, A.; Clark, R.M.; Owen, K.Q.; Koo, S.I.; Arjmandia, B.H. Dietary L-carnitine supplementation improves bone mineral density by suppressing bone turnover in aged ovariectomized rats. Phytomedicine, 2008, 15, 595-601.
104. Bd-Allah, A.R.; Al-Majed, A.A.; Al-Yahya, A.A.; Fouda, S.I.; Al- Shabana, O.A. L-Carnitine halts apoptosis and myelosuppression induced by carboplatin in rat bone marrow cell cultures (BMC). Arch. Toxicol., 2005, 79, 406-413. (Pubitemid 41040176)
105. Koverech, A.; Zallone, A. Use of isovaleryl L-carnitine to increase healing of bone fractures. US Patent, 6,906,102, 2005.
106. Benvenga, S.; Amato, A.; Calvani, M.; Trimarchi, F. Effects of carnitine on thyroid hormone action. Ann. N.Y. Acad. Sci., 2004, 1033, 158-167. (Pubitemid 39656748)
107. Sheweita, S.A.; Tilmisany, A.M.; Al-Sawaf, H. Mechanisms of male infertility: Role of antioxidants. Curr. Drug Metab., 2005, 6, 495-501. (Pubitemid 41300794)
108. Lenzi, A.; Lombardo, F.; Sgro, P. Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial. Fertil. Steril., 2003, 79, 292-300. (Pubitemid 36144052)
109. Vicari1, E.; Calogero, A.E. Effects of treatment with carnitines in infertile patients with prostato-vesiculo-epididymitis. Hum. Reprod., 2001, 16, 2338-2342. (Pubitemid 33054134)
110. Barhwal, K.; Hota, S.K.; Jain, V.; Prasad, D.; Singh, S.B.; Ilavazhagan, G. Acetyl-l-carnitine (ALCAR) prevents hypobaric hypoxia- induced spatial memory impairment through extracellular related kinase-mediated nuclear factor erythroid 2-related factor 2 phosphorylation. Neuroscience, 2009, 161, 501-514.
111. Brooks, J.O.; Yesavage, J.A.; Carta, A.; Bravi, D. Acetyl Lcarnitine slows decline in younger patients with Alzheimer's disease: a reanalysis of a double-blind, placebo-controlled study using the trilinear approach. Int. Psychogeriatr., 1998, 10, 193-203. (Pubitemid 28375550)
112. Brevetti, G.; di Lisa, F.; Perna, S.; Menabó, R.; Barbato, R.; Martone, V.D.; Siliprandi, N. Carnitine-related alterations in patients with intermittent claudication: indication for a focused carnitine therapy. Circulation, 1996, 93, 1685-1689. (Pubitemid 26131345)
113. Arrigo, A.; Casale, R.; Buonocore, M.; Ciano, C. Effects of acetyl- L-carnitine on reaction times in patients with cerebrovascular insufficiency. Int. J. Clin. Pharmacol. Res., 1990, 10, 133-137. (Pubitemid 20377889)
114. Kelly, G.S. L-carnitine: therapeutic applications of conditionallyessential amino amid. Alt. Med. Rev., 1998, 3, 345-360. (Pubitemid 128709612)
115. Jirillo, E.; Altamura, A.M.; Marcuccio, C.; Tortorella, C.; De Simonez, C.; Antonaci, S. Immunological responses in patients with tuberculosis and in vivo effects of acetyI-L-carnitine oral administration. Mediat. Inflamm., 1993, 2, 17-20.
116. Scarpini, E.; Sacilotto, G.; Baron, P.; Cusini, M.; Scarlato, G.J. Effect of acetyl-L-carnitine in the treatment of painful peripheral neuropathies in HIV+ patients. Peripher. Nerv. Syst., 1997, 2, 250-252. (Pubitemid 127690163)
117. Muller, D.M.; Seim, H.; Kiess, W.; Loster, H.; Richter, T. Effects of oral L-carnitine supplementation on in vivo long-chain fatty acid oxidation in healthy adults. Metabolism, 2002, 51, 1389-1391.
118. Galloway, S.D.R.; Broad, E.M. Oral L-carnitine supplementation and exercise metabolism. Monatsh. Chem., 2005, 136, 1391-1410. (Pubitemid 41095368)
119. Ransome, J.; Atterbom, H. The effects of L-carnitine on exercise lactate accumulation. Med. Sci. Sports Exerc., 1994, 26, 38.
120. Gorostiaga, E.M.; Maurer, C.A.; Eclache, J.P. Decrease in respiratory quotient during exercise following L-carnitine supplementation. Int. J. Sports Med., 1989, 10, 169-174. (Pubitemid 19160348)
121. Spasov, A.A.; Iiezhitsa, I.N. Stereopharmacology of carnitine Ross. Fiziol. Zh. Im. I. M. Sechenova., 2005, 91, 1469-1480.
122. Roberfroid, M.B. Global view on functional foods: European perspectives. Brit. J. Nutr., 2002, 88, 133-138.
123. Ashwell, M. Functional Foods: a simple scheme for establishing the scientific basis for all claims. Public Health Nutr., 2001, 4, 859-863.